Cargando…
Intranasal Mucosal Boosting with an Adenovirus-Vectored Vaccine Markedly Enhances the Protection of BCG-Primed Guinea Pigs against Pulmonary Tuberculosis
BACKGROUND: Recombinant adenovirus-vectored (Ad) tuberculosis (TB) vaccine platform has demonstrated great potential to be used either as a stand-alone or a boost vaccine in murine models. However, Ad TB vaccine remains to be evaluated in a more relevant and sensitive guinea pig model of pulmonary T...
Autores principales: | Xing, Zhou, McFarland, Christine T., Sallenave, Jean-Michel, Izzo, Angelo, Wang, Jun, McMurray, David N. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689939/ https://www.ncbi.nlm.nih.gov/pubmed/19516906 http://dx.doi.org/10.1371/journal.pone.0005856 |
Ejemplares similares
-
rBCG Induces Strong Antigen-Specific T Cell Responses in Rhesus Macaques in a Prime-Boost Setting with an Adenovirus 35 Tuberculosis Vaccine Vector
por: Magalhaes, Isabelle, et al.
Publicado: (2008) -
Intranasal infection and contact transmission of Zika virus in guinea pigs
por: Deng, Yong-Qiang, et al.
Publicado: (2017) -
Boosting with recombinant MVA expressing M. tuberculosis α-crystallin antigen augments the protection imparted by BCG against tuberculosis in guinea pigs
por: Nangpal, Prachi, et al.
Publicado: (2017) -
Accelerated heterologous prime-boost adenovirus vector-based SIV vaccine in neonatal rhesus monkeys
por: Liu, J, et al.
Publicado: (2012) -
Stimulation of anti-tumour immunity in guinea-pigs by methanol extraction residue of BCG.
por: Wainberg, M. A., et al.
Publicado: (1976)